Диссертация (1139673), страница 41
Текст из файла (страница 41)
Faravardeh, M. Eickhoff, S. Jackson, R. Sponset al. //Transplantation. — 2013. — Vol. 96, № 12. — P. 1089-1096.296131.Finelli L. National surveillance of dialysis-associated diseases in the UnitedStates, 2002 / L. Finelli, J.T. Miller, J.I. Tokars, M.J. Alter, M.J. Arduino // Seminars indialysis. — 2005. — Vol. 18, №1. — P. 52— 61.132.Fissell R.B. Patterns of hepatitis C prevalence and seroconversion inhemodialysis units from three continents: the DOPPS / R.B. Fissell, J.L. Bragg-Gresham,J.D. Woods, M. Jadoul, et al. // Kidney Int.
— 2004. — Vol. 65. — P. 2335— 2342.133.Fishman J.A. Infection in solid-organ transplant recipients / J.A. Fishman //. Engl. J. Med . — 2007. — Vol.357. — P.2601-2614.134.Foley D.P. Long-term outcomes of kidney transplantation in recipients 60years of age and older at the University of Florida / D.P.
Foley, P.R. Patton, H.U. MeierKriesche et al.// Clin. Transpl.— 2005. — P. 101-109.135.FoucherY.A clinical scoring system highly predictive of long-term kidneygraft survival / Y. Foucher,P.Daguin,A.Akl,M.Kessler et al. // Kidney Int.— 2010. —Vol. 78, № 12. — P. 1288-1294.136.Franke G.H. Aspects of quality of life through end-stage renal disease / G.H.Franke, J.
Reimer, T. Philipp // Qual. Life Res. — 2003. — Vol. 12. — P. 103-115.137.Frei U. Pre-transplant hypertension: a major risk factor for chronicprogressive renal allograft dysfunction / U. Frei, R. Schindler, D. Wieterset al. // Nephrol.Dial. Transplant. — 1995. — Vol.10. — P. 1206-1211.138.FreiU. Prevalence and management of anaemia in renal transplant recipients— a European survey (TRESAM) / Y.
Vanrenterghem, C.Ponticelli, J.M. Moraleset al.// Am. J. Transplant.— 2003.— Vol. 3.— P. 835-845.139.Guedes A.M. Over ten-year kidney graft survival determinants / A.M.Guedes, J. Malheiro, I. Fonseca, L.S. Martionset al. // Intern.J. Nephrol. — 2012. — ID302974. — 5 pages.140.Galante N.Z. Acute rejection is a risk factor for long-term survival in asingle-center analysis of 1544 renal transplants / N.Z. Galante, H.S. Tedesco, P.G.P.Machado et al. // Transplant. Proc. — 2002. — Vol. 34. — P. 508-513.141.Garcia-Garcia G. The global role of kidney transplantation / G.
Garcia-Garcia, P. Harden, J. Chapman// Ind. J. Nephrol. — 2012. — Vol. 22, №2. — P.77-82.297142.Gaspari F. Performance of different prediction equations for estimating renalfunction in kidney transplantation / F.Gaspari, S.Ferrari, N.Stucchi, et al. //Am. J.Transplant. — 2004.
— Vol.4, №11. — P.1826-1835.143.Gaston R.S. Current and evolving immunosuppressive regimens in kidneytransplantation /R.S. Gaston //Am. J. Kidney. Dis.— 2006. — Vol. 47, №4. — Suppl. 2.— S. 23-21.144.Geddes C.C.The impact of delayed graft function on the long-term outcomeof renal transplantation /C.C. Geddes, Y.M. Woo, A.G. Jardine //J. Nephrol.— 2002. —Vol.15, №1. — P. 17-21.145.Gjertson D.W. Impact of delayed graft function and acute rejection onkidney graft survival / D.W.
Gjertson// Clin. Transpl. — Los Angeles: UCLA TissueTyping Laboratory. — 2000. — P. 467-480.146.Gjertson D.W. Look-up survival- tables for renal transplantation / D.W.Gjertson// Clin. Transpl. — Los Angeles: UCLA Tissue Typing Laboratory, 1997. — P.337-383.147.Gjertson D.W. The role of death in kidney graft failure / D.W. Gjertson//Clin. Transpl. — Los Angeles: UCLA Tissue Typing Laboratory, 1998.
— P. 399-411.148.Global knowledge base on transplantation. ReportoftheWHO. 2014. /[Электронныйресурс].—Режимдоступа:http://www.who.int/transplantation/gkt/statistics/en/149.Gokol R. Cadaveric Transplantation / R. Gokol // J. Postgrad. Med. — 1993.— Vol.39. — P. 105.150.Guedes A.M. Over ten-year kidney graft survival determinants / A.M.Guedes, J. Malheiro, I. Fonseca, L.S. Martionset al. // Intern.J. Nephrol. — 2012. — ID302974. — 5 pages.151.Guidelines Subcommittee. World Health Organization.
International Societyof Hypertension Guidelines for the management of hypertension // J. Hypertenz. — 1999.— Vol. 17. — Р. 151-183.152.HalimiJ.M. Urinary albumin excretion and the risk of graft loss and death inproteinuric and non-proteinuric renal transplant recipients / J.M.Halimi, M. Buchler,A.Al-Najjaret al. / Am. J. Transplant. — 2007. — Vol.7, №3. — P. 618-625.298153.Hammond E.C. Smoking and death ratesreport on forty-four months offollow-up of 187,783 men: Part 1.
Total mortality. Part 2. Deathrates by cause / E.C.Hammond, D. Horn. // JAMA. — 1958.— Vol. 166.— P. 1294-1308.154.Hariharan S. Improved graft survival after renal transplantation in the UnitedStates, 1988 to 1996 / S. Hariharan, C.P. Johnson, B.A. Bresnahan, S.E. Tarantoet al.//New Engl.
J. Med. — 2000. — Vol. 342, №9. — P. 605-612.155.Hariharan S. Long-term kidney transplant survival / S. Harihar//Am. J.Kidney Dis. — 2001. — Vol.38, №6. — Suppl 6. — Р. 44-50.156.Hariharan S. Post-transplant renal function in the first year predicts long-term kidney transplant survival / S. Hariharan, M.A. McBride, W.S. Cherikh, C.B.Tolleris //Kidney Int. — 2002.
— Vol.62, № 1.— P. 311-318.157.Hatamizadeh P. Recipient-related predictors of kidney transplantationoutcomes in the elderly / P. Hatamizadeh, M.Z. Molnar, E. Streja et al.// Clin. Transplant.— 2013. — Vol.27, №3. — P. 436-443.158.Hegeman R.L. Chronic rejection in renal allografts: importance ofcardiovascular risk factors / R.L. Hegeman, L.G. Hunsicker // Clin. Transpl.— 1995. —Vol. 9. — P. 135-139.159.Henry M. The Role of Embolic Protection Devices in Renal Angioplasty andStenting/ M. Henry, I. Henry, C. Klonaris et. al. // Vascul.
Dis. Managem. — 2007. —Vol.4, №3.160.Hillege H.L. Urinary albumin excretion predicts cardiovascular andnoncardiovascular mortality in general population / H.L. Hillege, V. Fidler, G.F.Dierckset al. // Circulation. — 2002. — Vol. 106, № 14. — P. 1777-1782.161.HLA compatibility and organ transplant survival. Collaborative TransplantStudy / G. Opelz, T.Wujciak, B.
Döhler et al. // Rev. Immunogenet. — 1999. — Vol. 1,№3. — P. 334-342.162.He X.X. Comparison of the predictive performance of eGFR formulae formortality and graft failure in renal transplant recipients / X. He, J. Moore, S. Shabir, et al.//Transplantation. — 2009. — Vol. 87, №3.— P. 384-392.163.Heffron T.G. Once-daily tacrolimus extended-release formulation: 1-yearpost-conversion in stable pediatric liver transplant recipients / T.G. Heffron, M.D.299Pescovitz, S. Florman, M. Kalayoglu // Am. J. Transplant. — 2007.
— Vol.7. — P. 16091615.164.Hurst F.P. Effect of Smoking on Kidney Transplant Outcomes: Analysis ofthe United States Renal Data System / F.P. Hurst, M. Altieri, P.P. Patel, T.R. Jindal etal.// Transplantation. — 2011. — Vol.92, №10. — P. 1101-1107.165.Investing in health research and development: Report of the Ad HocCommittee on Health and Research Relating to Future Intervention Options. — Geneva,Switzerland: The World Health Organization, 1996. — 324 p.166.Irish W.D.A risk prediction model for delayed graft function in the currentera of deceased donor renal transplantation / W.D.
Irish, J.N. Ilsley, M.A. Schnitzler,S.et al.//Am. J. Transplant.— 2010. — Vol.10, № 10. — P. 2279-2286.167.Isoniemi H. Histological chronic allograft damage index accurately predictschronic renal allograft rejection / H. Isoniemi, E. Taskinen, P. Häyry / Transplant. —1994. — Vol.58, №11. — P. 1195-1198.168.JhaV. Chronic kidney disease: global dimension and perspectives / V.Jha,G.Garcia-Garcia, K.Iseki, S. Naicker et al. //Lancet. — 2013. — Vol.382.
— P. 260-272.169.Joseph J.T. The impact of late acute rejection after cadaveric kidneytransplantation / J.T. Joseph, D.B. Kingsmore, B.J.R. Junor // Clin. Transplant. — 2001.— Vol.15. — P. 221-227.170.Kahan B.D. Optimisation of cyclosporin therapy in renal transplantation bya pharmacokinetic strategy / B.D. Kahan, J. Grevel // Transplantation. — 1988. — Vol.46.— P. 631-644.171.Kahan B.D. Therapeutic drug monitoring of immunosuppressant drugs inclinical practice / B.D. Kahan, P.
Keown, G.A. Levy, A. Johnston // Clin Ther. — 2002.— Vol.24. — P. 330-350.172.Kaplan B. Poor predictive value of serum creatinine for renal allograft loss /B. Kaplan, J. Schold, H.U. Meier-Kriesche // Am. J. Transplant. — 2003. — Vol.3, №12.— P. 1560-1565.173.Karuthu S. Common Infections in Kidney Transplant Recipients // S.Karuthu, E.A. Blumberg // Clin.
J. Am. Soc. Nephrol. — 2012. — Vol.7, №12. — P.2058-2070.300174.Kasiske B.L. A simple tool to predict outcomes after kidney transplant / B.L.Kasiske, A.K. Israni, J.J. Snyder, M.A. Skeans et al. //Am. J. Kidney Dis. — 2010. —Vol.56, №5. — P. 947-960.175.Kasiske B.L. Cigarette smoking in renal transplant recipients / B.L.
Kasiske,D. Klinger // J. Am. Soc. Nephrol. — 2000. — Vol.11. — P. 753-759.176.KasiskeB. Long-Term Deterioration of Kidney Allograft Function / B.Kasiske, R.S. Gaston, S. Gourishankar// Am. J. Transplant. — 2005. — Vol. 5. — P.1405-1414.177.Kasiske B.L. The evaluation and selection of living kidneys donors / B.L.Kasiske, M.J. Bia // Am. J.
Kidney Dis. — 1995. — Vol.26. — P. 387.178.KaysenG.A. Inflammation and reduced albumin synthesis associated withstable decline in serum albumin in hemodialysis patients / G.A.Kaysen, J.A.Dubin, H-G.Mülleret al. // Kidn. Internat. — Vol. 65, №4. — P. 1408-1415.179.KDIGO clinical practice guideline for the care of kidney transplant recipients/ Am J Transplant // 2009. — P.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
